Skip to main content

Labcorp statistics

  • LH · NYSE
  • Healthcare
  • Health Care Services
  • S&P 500
$370.48−0.49%Close 13 Nov 2026 · Market value $30.10B

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Labcorp is valued at $30.10B on its latest close. Its price is 30.0 times its earnings.

Market value$30.10B
Enterprise value$36.53B
Price / earnings29.98
Price / sales2.06
Price / book3.40
EV / EBITDA16.53
EV / sales2.50
Price / free cash flow23.39
Price / free cash flow, own 5-year average16.75
EV / EBIT24.33
EV / free cash flow28.40
Free cash flow yield4.3%
Dividend yield0.8%

Share price

Latest close$370.48
Day's change−0.5%
52-week high$375.10
52-week low$245.00
From 52-week high−1.2%
Return · 1 month+16.5%
Return · 3 months+11.3%
Return · year to date+47.7%
Return · 1 year+39.3%
Beta · 1 year against the S&P 5000.36
50-day average$329.64
200-day average$292.41
RSI 1469.5
Average volume · 20 sessions783K

Margins and returns

For fiscal 2025, as filed.

Gross margin28.8%
Operating margin9.9%
Net margin6.3%
Free cash flow margin8.6%
Return on equity10.5%
Return on assets5.9%
Return on invested capital7.0%
Return on invested capital, 5-year average7.5%
Return on capital employed9.0%
Stock-based compensation / revenue0.9%

Financial position

At the end of fiscal 2025.

Cash and equivalents$532.3M
Total debt$6.46B
Net debt$5.93B
Current ratio1.42
Quick ratio0.95
Debt / equity0.75
Net debt / EBITDA2.87
Interest coverage6.18

Growth

Revenue, latest quarter on a year+6.9%
Revenue, twelve months on a year+6.0%
EPS, latest quarter on a year+3.2%
EPS, twelve months on a year+19.6%
Revenue, 5-year compound−0.0%
Revenue, 10-year compound+4.9%
Net income, 5-year compound−10.8%
Free cash flow, 5-year compound−7.2%
EPS, 5-year compound−8.0%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares83.8M
Shares outstanding, 5-year compound−3.1%
Net share repurchases$447.5M
Dividends per share$2.88
Dividend payout27.5%

Taxes

For fiscal 2025, as filed.

Income tax expense$229.8M

LH in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.